PUBLICATION

Zebrafish-based small molecule screens for novel cardiovascular drugs

Authors
Novodvorsky, P., da Costa, M.M.J., and Chico, T.J.A.
ID
ZDB-PUB-131010-4
Date
2013
Source
Drug Discovery Today: Technologies   10(1): e109-e114 (Review)
Registered Authors
Chico, Tim J.
Keywords
none
MeSH Terms
  • Animals
  • Cardiovascular Agents*
  • Drug Evaluation, Preclinical
  • High-Throughput Screening Assays*
  • Zebrafish*
PubMed
24050238 Full text @ Drug Discov. Today Technol.
Abstract

The zebrafish is increasingly being adopted as an in vivo model of high throughput drug screening. In this brief review we outline the advantages and disadvantages of this approach and summarize recent screens that have attempted to identify novel small molecules with activity on the cardiovascular system.

Genes / Markers
Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping